IOL CHEMICALS & PHARM. | PIRAMAL PHARMA | IOL CHEMICALS & PHARM./ PIRAMAL PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 16.3 | -473.5 | - | View Chart |
P/BV | x | 1.5 | 2.9 | 49.8% | View Chart |
Dividend Yield | % | 1.1 | 0.0 | - |
IOL CHEMICALS & PHARM. PIRAMAL PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
PIRAMAL PHARMA Mar-23 |
IOL CHEMICALS & PHARM./ PIRAMAL PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 202 | 266.0% | |
Low | Rs | 272 | 63 | 431.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 59.3 | 636.4% | |
Earnings per share (Unadj.) | Rs | 23.7 | -1.6 | -1,516.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 4.1 | 768.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 56.8 | 452.4% | |
Shares outstanding (eoy) | m | 58.71 | 1,193.32 | 4.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.2 | 48.0% | |
Avg P/E ratio | x | 17.1 | -84.8 | -20.1% | |
P/CF ratio (eoy) | x | 12.8 | 32.2 | 39.7% | |
Price / Book Value ratio | x | 1.6 | 2.3 | 67.5% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 158,073 | 15.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 18,964 | 8.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 70,816 | 31.3% | |
Other income | Rs m | 256 | 2,251 | 11.4% | |
Total revenues | Rs m | 22,427 | 73,067 | 30.7% | |
Gross profit | Rs m | 2,257 | 6,756 | 33.4% | |
Depreciation | Rs m | 462 | 6,767 | 6.8% | |
Interest | Rs m | 165 | 3,442 | 4.8% | |
Profit before tax | Rs m | 1,887 | -1,202 | -157.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 663 | 74.7% | |
Profit after tax | Rs m | 1,391 | -1,865 | -74.6% | |
Gross profit margin | % | 10.2 | 9.5 | 106.7% | |
Effective tax rate | % | 26.2 | -55.2 | -47.6% | |
Net profit margin | % | 6.3 | -2.6 | -238.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 48,435 | 20.0% | |
Current liabilities | Rs m | 5,025 | 38,510 | 13.0% | |
Net working cap to sales | % | 20.9 | 14.0 | 149.4% | |
Current ratio | x | 1.9 | 1.3 | 152.9% | |
Inventory Days | Days | 43 | 58 | 74.1% | |
Debtors Days | Days | 8 | 9 | 89.7% | |
Net fixed assets | Rs m | 11,017 | 95,931 | 11.5% | |
Share capital | Rs m | 587 | 11,933 | 4.9% | |
"Free" reserves | Rs m | 14,490 | 55,802 | 26.0% | |
Net worth | Rs m | 15,077 | 67,735 | 22.3% | |
Long term debt | Rs m | 0 | 33,835 | 0.0% | |
Total assets | Rs m | 20,684 | 144,365 | 14.3% | |
Interest coverage | x | 12.5 | 0.7 | 1,913.3% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.5 | 218.5% | |
Return on assets | % | 7.5 | 1.1 | 688.6% | |
Return on equity | % | 9.2 | -2.8 | -335.2% | |
Return on capital | % | 13.6 | 2.2 | 616.8% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 20,478 | 29.0% | |
Fx outflow | Rs m | 6,052 | 6,734 | 89.9% | |
Net fx | Rs m | -122 | 13,744 | -0.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 4,839 | 25.3% | |
From Investments | Rs m | -1,200 | -13,388 | 9.0% | |
From Financial Activity | Rs m | -41 | 8,178 | -0.5% | |
Net Cashflow | Rs m | -18 | -320 | 5.8% |
Indian Promoters | % | 48.2 | 35.0 | 137.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 42.7 | 4.0% | |
FIIs | % | 1.4 | 30.6 | 4.6% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 65.0 | 79.7% | |
Shareholders | 130,003 | 297,996 | 43.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | PIRAMAL PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.73% | -0.23% | 0.70% |
1-Month | -4.78% | 5.52% | 1.16% |
1-Year | -10.81% | 105.05% | 53.06% |
3-Year CAGR | -15.31% | -8.03% | 13.70% |
5-Year CAGR | 17.08% | -4.90% | 21.57% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the PIRAMAL PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of PIRAMAL PHARMA the stake stands at 35.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of PIRAMAL PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
PIRAMAL PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of PIRAMAL PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.